ZA828580B - Interferon formulations - Google Patents

Interferon formulations

Info

Publication number
ZA828580B
ZA828580B ZA828580A ZA828580A ZA828580B ZA 828580 B ZA828580 B ZA 828580B ZA 828580 A ZA828580 A ZA 828580A ZA 828580 A ZA828580 A ZA 828580A ZA 828580 B ZA828580 B ZA 828580B
Authority
ZA
South Africa
Prior art keywords
interferon formulations
interferon
formulations
Prior art date
Application number
ZA828580A
Other languages
English (en)
Inventor
Henry King Hong Kwan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to DE8282111665T priority Critical patent/DE3262575D1/de
Priority to AT82111665T priority patent/ATE12073T1/de
Priority to EP82111665A priority patent/EP0082481B2/de
Priority to NO82824285A priority patent/NO161036C/no
Priority to IL67517A priority patent/IL67517A/xx
Priority to AU91688/82A priority patent/AU558966B2/en
Priority to PH28296A priority patent/PH19869A/en
Priority to NZ202856A priority patent/NZ202856A/en
Priority to FI824366A priority patent/FI70794C/fi
Priority to IE3046/82A priority patent/IE54468B1/en
Priority to OA57876A priority patent/OA07282A/xx
Priority to CA000418237A priority patent/CA1207665A/en
Priority to DK565882A priority patent/DK158873C/da
Priority to PT76013A priority patent/PT76013B/pt
Priority to HU824137A priority patent/HU190649B/hu
Priority to US06/532,886 priority patent/US4496537A/en
Publication of ZA828580B publication Critical patent/ZA828580B/xx
Priority to SG706/87A priority patent/SG70687G/en
Priority to HK944/87A priority patent/HK94487A/xx
Priority to MY705/87A priority patent/MY8700705A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA828580A 1981-12-23 1982-11-19 Interferon formulations ZA828580B (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DE8282111665T DE3262575D1 (en) 1981-12-23 1982-12-15 Stabilised interferon formulations and their preparation
AT82111665T ATE12073T1 (de) 1981-12-23 1982-12-15 Stabilisierte interferon-zusammensetzungen und ihre herstellung.
EP82111665A EP0082481B2 (de) 1981-12-23 1982-12-15 Stabilisierte alpha-Interferon-Zusammensetzungen und ihre Herstellung
NO82824285A NO161036C (no) 1981-12-23 1982-12-20 Fremgangsmaate ved fremstilling av et frysetoerret, farmasoeytisk interferonpreparat.
IL67517A IL67517A (en) 1981-12-23 1982-12-20 Stabilized alpha-interferon formulations and their preparation
AU91688/82A AU558966B2 (en) 1981-12-23 1982-12-20 Interferon and amino acid as stabilizer
PH28296A PH19869A (en) 1981-12-23 1982-12-20 Interferon formulation
NZ202856A NZ202856A (en) 1981-12-23 1982-12-20 Stabilised,lyophilised pharmaceutical composition comprising interferon and amino acid
FI824366A FI70794C (fi) 1981-12-23 1982-12-20 Foerfarande foer stabilisering av en lyofiliserad farmaceutiskinterferonblandning
IE3046/82A IE54468B1 (en) 1981-12-23 1982-12-21 Stabilised interferon formulations and their preparation
OA57876A OA07282A (fr) 1981-12-23 1982-12-21 Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation.
CA000418237A CA1207665A (en) 1981-12-23 1982-12-21 Interferon formulations
DK565882A DK158873C (da) 1981-12-23 1982-12-21 Fremgangsmaade til stabilisering af et lyofiliseret farmaceutisk interferonpraeparat
PT76013A PT76013B (en) 1981-12-23 1982-12-21 Process for preparing interferon formulations
HU824137A HU190649B (en) 1981-12-23 1982-12-22 Process for the preparation of compositions containing interferon
US06/532,886 US4496537A (en) 1981-12-23 1983-09-16 Biologically stable alpha-interferon formulations
SG706/87A SG70687G (en) 1981-12-23 1987-08-27 Stabilised interferon formulations and their preparation
HK944/87A HK94487A (en) 1981-12-23 1987-12-10 Stabilised interferon formulations and their preparation
MY705/87A MY8700705A (en) 1981-12-23 1987-12-30 Stabilised interferon formulations and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33405281A 1981-12-23 1981-12-23

Publications (1)

Publication Number Publication Date
ZA828580B true ZA828580B (en) 1983-10-26

Family

ID=23305374

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA828580A ZA828580B (en) 1981-12-23 1982-11-19 Interferon formulations
ZA829344A ZA829344B (en) 1981-12-23 1982-12-20 Interferon formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA829344A ZA829344B (en) 1981-12-23 1982-12-20 Interferon formulations

Country Status (3)

Country Link
JP (1) JPS58146504A (de)
KR (1) KR880002037B1 (de)
ZA (2) ZA828580B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
JPS60243028A (ja) * 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd インタ−フエロンの可溶化方法
NZ217885A (en) * 1985-10-15 1989-06-28 Hoffmann La Roche Stabilised compositions of interferon
JP2577744B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
CA1327161C (en) * 1987-09-01 1994-02-22 Mitsugu Kobayashi Lyophilized pharmaceutical composition of neocarzinostatin derivative
WO1996016658A1 (fr) * 1994-11-29 1996-06-06 Kyowa Hakko Kogyo Co., Ltd. Preparation a base d'un derive d'indolocarbazol
NZ534598A (en) * 2002-02-01 2004-11-26 Shimoda Biotech Pty Ltd Pharmaceutical composition
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon

Also Published As

Publication number Publication date
ZA829344B (en) 1983-10-26
KR880002037B1 (ko) 1988-10-13
JPH0543689B2 (de) 1993-07-02
KR840002657A (ko) 1984-07-16
JPS58146504A (ja) 1983-09-01

Similar Documents

Publication Publication Date Title
IL67517A0 (en) Interferon formulations
CY1430A (en) Pharmaceutical formulations
DE3262847D1 (en) Heat-polymerisable compositions
ZA828580B (en) Interferon formulations
ZA844045B (en) Interferon gel formulations
DE3263502D1 (en) Flavour-release compositions
GB2105190B (en) Light-screen compositions
JPS57174020A (en) Combine
JPS57188524A (en) Interferon
JPS57174021A (en) Combine
JPS57174018A (en) Combine
JPS57159415A (en) Combine
JPS57174019A (en) Combine
JPS57198004A (en) Mowering combine
JPS57198015A (en) Combine
CS175282A2 (en) Herbicidni prostredek s prodlouzenou stalosti v pude
GB2105744B (en) Sulfur-aggregate compositions
JPS57174016A (en) Combine
JPS57189611A (en) Combine
JPS57177613A (en) Combine
JPS57174013A (en) Combine
JPS57202207A (en) Mowering combine
JPS57174017A (en) Combine
JPS57202208A (en) Mowering combine
JPS57198003A (en) Mowering combine